IU, Purdue get $2.55M to study breast cancer

September 30, 2017

Researchers at Indiana University and Purdue University have received $2.55 million from Susan G. Komen to study possible new treatments.

IU and its researchers will get $2.1 million to study why some patients suffer chemotherapy-related side effects; to understand how RNA controls genes in breast cancer; to understand the molecular mechanisms involved in estrogen-receptor positive cancer growth; and to support the collection and storage of whole blood, DNA serum, plasma and healthy breast tissue at the IU Simon Cancer Center.

Purdue and its researchers will get $450,000 to study how to enhance the immune system’s natural ability to fight breast cancer through the protein PD-L1.•


Recent Articles by IBJ Staff

Comments powered by Disqus